UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000010284
Receipt No. R000012042
Official scientific title of the study Research for the treatment of inflammation of small airways in asthma
Date of disclosure of the study information 2013/05/01
Last modified on 2018/08/24 (Ver. 10)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Research for the treatment of inflammation of small airways in asthma
Title of the study (Brief title) Research for the treatment of small airways in asthma
Region
Japan

Condition
Condition asthma
Classification by specialty
Medicine in general Pneumology Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To invesgtigate differences in the effects of particle sizes of inhaled medication on small airways in asthma
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Effects on small airways inflammation of
Key secondary outcomes Effects on various clinical indices including adherence

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Salmeterol/Fluticasone discus
Interventions/Control_2 Salmeterol/Fluticasone aerosol
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria adult asthma
Key exclusion criteria tuberculosis, oneumonia, interstitial pneumonia, lung cancer
Target sample size 40

Research contact person
Name of lead principal investigator Hisako Matsumoto
Organization Graduate School on Medicine, Kyoto University
Division name Respiratory Medicine
Address 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan
TEL +81-75-751-3830
Email hmatsumo@kuhp.kyoto-u.ac.jp

Public contact
Name of contact person Tadao Nagasaki
Organization Graduate School on Medicine, Kyoto University
Division name Respiratory Medicine
Address 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan
TEL +81-75-751-3830
Homepage URL
Email nagasaki@kuhp.kyoto-u.ac.jp

Sponsor
Institute Department of Respiratory Medicine, Graduate School on Medicine, Kyoto University
Institute
Department

Funding Source
Organization selffunding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 05 Month 01 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2013 Year 03 Month 20 Day
Anticipated trial start date
2013 Year 05 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 03 Month 20 Day
Last modified on
2018 Year 08 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000012042